Evaluating The effectiveness of Reducing Price Barriers to Pediatric Fever Care on Caregiver Decision-making and Illness Outcomes
How to cite
Dieci, Maria; Paramo, Carlos. 2026. "Evaluating The effectiveness of Reducing Price Barriers to Pediatric Fever Care on Caregiver Decision-making and Illness Outcomes." AEA RCT Registry. AEARCTR-0019380. https://doi.org/10.1257/rct.19380-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Background: Febrile illness is a leading cause of serious illness and death for millions of children across sub-
Saharan Africa, despite the availability of diagnostics and appropriate medications. Unfortunately, many fevers
are not treated appropriately due to financial barriers, incorrect or no diagnosis, and inappropriate use of
medications. Inappropriate treatment has uncertain health and economic costs to individuals as well as at a
population level. Objective: The primary objective of this trial is to determine the effectiveness and cost-
effectiveness of pharmacy-based discounts for appropriately dosed azithromycin compared with incentives for
facilitated referrals to a higher level health care facility in the management of malaria negative fevers in children
under five years in Uganda
Intervention
Control group: All study sites, including the control, have access to price subsidies for ORS, malaria RDTs, malaria ACTs, and over-the- counter painkillers. All study sites, including the control, will have access to referral information to nearby clinics.
Azithromycin discount group: Pharmacies assigned to this arm, in addition to having access to the subsidies and information described in the control group, will also have access to subsidized azithromycin for malaria negative children under 5.
Facilitated referral group: In addition to what is described for the control group, this arm will have access to subsidies for facilitated referrals to nearby clinics (incentives for patients and providers to complete referrals).
Experimental design
A sample of 200 eligible pharmacies in Uganda will be randomized into one of three study arms: (1) a control group, (2) a discounted azithromycin group, which offers subsidized prices for Azithromycin to eligible pediatric febrile cases who seek care in the pharmacy, (3) a facilitated referral group, which provides transport allowances facilitate referral visits for follow up care at nearby clinics to eligible pediatric febrile cases who seek care in the pharmacy
Design details
Cited by
No citation data available for this registration yet.